The Opportunity

insitro is a physical AI company dedicated to unlocking causal human biology and accelerating the delivery of better medicines to patients. Our unique Virtual Human™ platform identifies novel, high-impact genetic intervention points, which our TherML™ platform translates into therapeutics—whether small molecules, biologics, or oligos. With multiple programs in metabolic disease and neuroscience advancing toward the clinic, and our first IND submission slated for the second half of this year, we are at a pivotal inflection point.

We are looking for a Senior Director of Quality Assurance to build a pragmatic, inspection-ready quality function for clinical-stage operations. You will own insitro's approach to GMP and GCP quality, clinical data quality oversight, and data integrity, at the intersection of outsourced development, clinical execution, and AI-enabled R&D. This is a senior individual contributor role, with growth opportunities as our pipeline grows. You will be personally accountable for building insitro’s Quality systems: standing up our QMS and SOPs, overseeing or conducting vendor/site audits, while serving as the company's quality voice with executives, partners, and the board.

Based in South San Francisco, this position reports directly to the Chief Technology Operations Officer and offers an in-person hybrid schedule of either three days per week or one full week per month.

Responsibilities

Quality Management System

Own the Operating System: Lead the evolution of insitro's QMS beyond initial setup into an active, effective system

Build and Scale Core Processes: Mature CAPA, deviations, change control, training, and document management to support organizational growth

Author the Standards: Write, revise, and implement SOPs, policies, and quality workflows as the business requires

GXP Oversight & Vendor Quality

Qualify and Audit Partners: Own qualification, audits, and quality agreements across CDMOs, CROs, and investigator sites

Facilitate GMP Release: Provide hands-on oversight of product release, batch record review, stability programs, and annual product reviews through Phase 2 in partnership with CMC

Own Clinical Quality: Lead TMF quality, clinical audit planning, and sponsor oversight activities in partnership with clinical operations and data management

Drive Inspection Readiness: Prepare the organization for pre-IND, IND, and BIMO milestones and lead sponsor-side response to findings

Data Integrity & AI-Enabled Workflows

Set the Data Integrity Bar: Define expectations for documentation, traceability, review, and change control from raw biological data through clinical insight

System and Data Validation: Partner with Compute and Data Science on model documentation, change control, and validation approaches for clinical applications of AI/ML outputs informing patient selection, biomarker selection, and trial design

Manage Continuous Change: Develop phase-appropriate approaches to model drift and evolving algorithms that hold up under regulatory scrutiny

Executive & Cross-Functional Leadership

Support External Discussions: Contribute quality and data integrity context to partnership and diligence conversations as needed

Build Credibility Across Functions: Partner with research, clinical, regulatory, CMC, and data science teams to integrate quality into workflows, and development approaches

About You

Experience & Qualifications

Proven Tenure: 12+ years in pharma or biotech quality, with progression into senior QA leadership.

Small-Company Track Record: You have advanced a molecule from preclinical development through IND and into Phase 2 or beyond in a resource-constrained environment with substantial outsourced execution.

GXP Bridge: Deep expertise in either GMP or GCP with genuine working competence in the other.

Systems Builder: Hands-on experience configuring or materially building a QMS such as ZenQMS, Veeva Vault QMS, Qualio, MasterControl, or TrackWise.

Data Integrity Command: Strong grounding in data integrity and computer system validation fundamentals, including ALCOA+, 21 CFR Part 11, GAMP 5 categorization, and audit trail review.